Internal Server Error

BioTissue - About the company

BioTissue is a series C company based in Miami (United States), founded in 2001. It operates as a Developer of regenerative biologic therapies for eye care. BioTissue has raised $110M in funding from investors like Ballast Point Ventures, RC Capital and EW Healthcare Partners. The company has 2811 active competitors, including 929 funded and 695 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, Tango Therapeutics and Elicio.

Company Details

Developer of regenerative biologic therapies for eye care. The company offers a range of products that aim to help improve patient outcomes in regenerative wound healing AmnioGraft, Prokera, Neox 1K, and more.
Social
XFacebook
Phone Number
+1 **********
Registered Address
Miami, Florida
Key Metrics
Founded Year
2001
Location
Stage
Series C
Total Funding
$110M in 19 rounds
Ranked
Employee Count
376 as on Sep 30, 2026
Similar Companies
Sign up to download BioTissue's company profile

BioTissue's funding and investors

BioTissue has raised a total funding of $110M over 19 rounds. Its first funding round was on Sep 15, 2006. Its latest funding round was a Grant (prize money) round on Jun 21, 2021 for $*****. 1 investor participated in its latest round. BioTissue has 4 institutional investors.

Here is the list of recent funding rounds of BioTissue:lockFilter this list
Date of Funding
Funding Amount
Round Name
Post-Money Valuation
Revenue Multiple
Lead Investors
Other Investors
Jun 21, 2021
6896607
Grant (prize money)
5005627
7376623
1978747
4635146
Apr 12, 2019
3428600
Series C
1453584
5939821
6755892
Nov 18, 2016
4076986
Grant (prize money)
4873741
9492227
9898402
lockAccess funding benchmarks and valuations. Sign up today!

BioTissue's founders and board of directors

Founder? Claim Profile

BioTissue's employee count trend

BioTissue has 376 employees as of Sep 26. Here is BioTissue's employee count trend over the years:
Employee count trend for BioTissue
lockUncover BioTissue's growth story! Sign up today!
chrome_extension_cta_illustration
Access Tracxn on any website
Our Google Chrome extension lets you view company details while browsing their websites
Install Tracxn Extension

BioTissue's Competitors and alternates

Top competitors of BioTissue include Jazz Pharmaceuticals, Tango Therapeutics and Elicio. Here is the list of Top 10 competitors of BioTissue, ranked by Tracxn score:
Rank
Company Details
Short Description
Total Funding
Investors
Tracxn Score
1st
Logo for Jazz Pharmaceuticals
Jazz Pharmaceuticals
2003, Dublin (Ireland), Public
Developer of novel biopharmaceutical medicines for unmet medical needs
$265M
82/100
2nd
Logo for Tango Therapeutics
Tango Therapeutics
2017, Cambridge (United States), Public
Developer of drugs for the treatment of cancer
$165M
72/100
3rd
Logo for Elicio
Elicio
2012, Cambridge (United States), Public
Developer of vaccines for treating cancer
$47.4M
72/100
4th
Logo for Immuneel
Immuneel
2018, Bengaluru (India), Series B
Developer of T-cell therapies for the treatment of cancer
$49.8M
71/100
5th
Logo for BioNTech
BioNTech
2008, Mainz (Germany), Public
Developer of immunotherapeutics for the treatment of cancer and other diseases
$861M
71/100
6th
Logo for Erasca
Erasca
2018, San Diego (United States), Public
Developer of small molecule based therapeutics for cancer
$300M
71/100
7th
Logo for Viridian Therapeutics
Viridian Therapeutics
2007, Boulder (United States), Public
Developer of medicines for patients with serious and rare diseases
$14.5M
71/100
8th
Logo for Philogen
Philogen
1996, Sovicille (Italy), Public
Developer of antibody based drugs for angiogenesis-related cancer and inflammatory disorders
$69.7M
70/100
9th
Logo for Ideaya Biosciences
Ideaya Biosciences
2015, San Francisco (United States), Public
Developer of oncology-focused precision medicine using molecular diagnostics
$157M
70/100
10th
Logo for Deciphera
Deciphera
2003, Waltham (United States), Acquired
Developer of type 2 kinase inhibitors for treating cancer
$173M
70/100
498th
Logo for BioTissue
BioTissue
2001, Miami (United States), Series C
Developer of regenerative biologic therapies for eye care
$110M
49/100
lockGet insights and benchmarks for competitors of 2M+ companies! Sign up today!
Looking for more details on BioTissue's competitors? Click here to see the top ones

BioTissue's Investments and acquisitions

BioTissue has made no investments or acquisitions yet.

Reports related to BioTissue

Here is the latest report on BioTissue's sector:

News related to BioTissue

lockFilter this list
Media has covered BioTissue for a total of 2 events in the last 1 year.
•
BioTissue Completes Name ChangeEyewire News•Jun 14, 2024•BioTissue
•
TissueTech Is Officially BioTissueOrthopedics•Nov 15, 2022•BioTissue
lockGet curated news about company updates, funding rounds, M&A deals and others. Sign up today!

FAQs about BioTissue

Explore our recently published companies
Tracxn powers 1,000+ customers across 30+ countries
Accel PartnersPartechIN-Q-TEL - USFujitsuTenityStanford